Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Kaposi's sarcoma will be initial focus of NCI's Gallo's new outside Institute of Human Virology.

Executive Summary

KAPOSI's SARCOMA HORMONAL CONTROL TO BE A FOCUS OF GALLO's INSTITUTE of Human Virology to be located at the University of Maryland at Baltimore. Chief of the National Cancer Institute's Division of Cancer Etiology laboratory of tumor cell biology since 1972, Robert Gallo, MD, announced his planned departure from NCI and the establishment of the new institute May 24. The institute's new facilities are expected to be completed by September or October. Gallo is expected to remain at NCI until the facilities are open.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS026320

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel